<?xml version="1.0" encoding="UTF-8"?>
<ref id="jcp29785-bib-0035">
 <mixed-citation publication-type="journal" id="jcp29785-cit-0035">
  <string-name>
   <surname>Liu</surname>, 
   <given-names>F.</given-names>
  </string-name>, 
  <string-name>
   <surname>Xu</surname>, 
   <given-names>A.</given-names>
  </string-name>, 
  <string-name>
   <surname>Zhang</surname>, 
   <given-names>Y.</given-names>
  </string-name>, 
  <string-name>
   <surname>Xuan</surname>, 
   <given-names>W.</given-names>
  </string-name>, 
  <string-name>
   <surname>Yan</surname>, 
   <given-names>T.</given-names>
  </string-name>, 
  <string-name>
   <surname>Pan</surname>, 
   <given-names>K.</given-names>
  </string-name>, … 
  <string-name>
   <surname>Zhang</surname>, 
   <given-names>J.</given-names>
  </string-name> (
  <year>2020</year>). 
  <article-title>Patients of COVID‐19 may benefit from sustained lopinavir‐combined regimen and the increase of eosinophil may predict the outcome of COVID‐19 progression</article-title>. 
  <source xml:lang="en">International Journal of Infectious Diseases</source>, 
  <volume>95</volume>, 
  <fpage>183</fpage>–
  <lpage>191</lpage>.
  <pub-id pub-id-type="pmid">32173576</pub-id>
 </mixed-citation>
</ref>
